biopharmaapac.com Open in urlscan Pro
2a02:4780:3:644:0:683:abf2:2 Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwia...
Effective URL:
https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-...
Submission: On June 19 via api (June 19th 2023, 4:16:30 am UTC) from CA — Scanned from CA

Summary HTTP 73 Redirects Links 9 Behaviour Indicators

Summary

This website contacted 15 IPs in 3 countries across 12 domains to perform 73 HTTP transactions. The main IP is 2a02:4780:3:644:0:683:abf2:2, located in Singapore and belongs to AS-HOSTINGER, CY. The main domain is biopharmaapac.com.
TLS certificate: Issued by R3 on May 10th 2023. Valid for: 3 months.

This is the only time biopharmaapac.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 1	34.193.159.116 34.193.159.116	14618 (AMAZON-AES) (AMAZON-AES)
30	2a02:4780:3:6... 2a02:4780:3:644:0:683:abf2:2	47583 (AS-HOSTINGER) (AS-HOSTINGER)
9	2607:f8b0:402... 2607:f8b0:4020:805::200e	15169 (GOOGLE) (GOOGLE)
8	2607:f8b0:402... 2607:f8b0:4020:805::2004	15169 (GOOGLE) (GOOGLE)
2	2606:2800:220... 2606:2800:220:de:468:2285:c1:4a3	15133 (EDGECAST) (EDGECAST)
1	2607:f8b0:400... 2607:f8b0:4006:80d::2008	15169 (GOOGLE) (GOOGLE)
2	2607:f8b0:402... 2607:f8b0:4020:804::2003	15169 (GOOGLE) (GOOGLE)
1 2	2607:f8b0:402... 2607:f8b0:4020:807::2002	15169 (GOOGLE) (GOOGLE)
1	2607:f8b0:402... 2607:f8b0:4020:806::2006	15169 (GOOGLE) (GOOGLE)
4	2607:f8b0:402... 2607:f8b0:4020:804::200a	15169 (GOOGLE) (GOOGLE)
1	2607:f8b0:400... 2607:f8b0:4006:80a::2016	15169 (GOOGLE) (GOOGLE)
1	2607:f8b0:400... 2607:f8b0:4006:80b::2001	15169 (GOOGLE) (GOOGLE)
11	2607:f8b0:402... 2607:f8b0:4020:805::2003	15169 (GOOGLE) (GOOGLE)
1	2607:f8b0:402... 2607:f8b0:4020:807::200e	15169 (GOOGLE) (GOOGLE)
1	104.244.42.200 104.244.42.200	13414 (TWITTER) (TWITTER)
73	15

1 34.193.159.116 (Ashburn, United States) 1 redirects

ASN14618 (AMAZON-AES, US)
PTR: ec2-34-193-159-116.compute-1.amazonaws.com

t.dripemail2.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

30 2a02:4780:3:644:0:683:abf2:2 (Singapore)

ASN47583 (AS-HOSTINGER, CY)

biopharmaapac.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

9 2607:f8b0:4020:805::200e (Montreal, Canada)

ASN15169 (GOOGLE, US)

www.youtube.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

8 2607:f8b0:4020:805::2004 (Montreal, Canada)

ASN15169 (GOOGLE, US)

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2606:2800:220:de:468:2285:c1:4a3 (United States)

ASN15133 (EDGECAST, US)

platform.twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2607:f8b0:4006:80d::2008 (Flushing, United States)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2607:f8b0:4020:804::2003 (Montreal, Canada)

ASN15169 (GOOGLE, US)

fonts.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2607:f8b0:4020:807::2002 (Montreal, Canada) 1 redirects

ASN15169 (GOOGLE, US)

googleads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2607:f8b0:4020:806::2006 (Montreal, Canada)

ASN15169 (GOOGLE, US)

static.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2607:f8b0:4020:804::200a (Montreal, Canada)

ASN15169 (GOOGLE, US)

jnn-pa.googleapis.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2607:f8b0:4006:80a::2016 (Flushing, United States)

ASN15169 (GOOGLE, US)

i.ytimg.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2607:f8b0:4006:80b::2001 (Flushing, United States)

ASN15169 (GOOGLE, US)

yt3.ggpht.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

11 2607:f8b0:4020:805::2003 (Montreal, Canada)

ASN15169 (GOOGLE, US)

www.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2607:f8b0:4020:807::200e (Montreal, Canada)

ASN15169 (GOOGLE, US)

www.google-analytics.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 104.244.42.200 (United States)

ASN13414 (TWITTER, US)

syndication.twitter.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
30	biopharmaapac.com biopharmaapac.com	1 MB
13	gstatic.com fonts.gstatic.com www.gstatic.com	978 KB
9	youtube.com www.youtube.com — Cisco Umbrella Rank: 97	961 KB
8	google.com www.google.com — Cisco Umbrella Rank: 3	74 KB
4	googleapis.com jnn-pa.googleapis.com — Cisco Umbrella Rank: 279	31 KB
3	doubleclick.net 1 redirects googleads.g.doubleclick.net — Cisco Umbrella Rank: 57 static.doubleclick.net — Cisco Umbrella Rank: 349	1 KB
3	twitter.com platform.twitter.com — Cisco Umbrella Rank: 959 syndication.twitter.com — Cisco Umbrella Rank: 1131	132 KB
1	google-analytics.com www.google-analytics.com — Cisco Umbrella Rank: 60	255 B
1	ggpht.com yt3.ggpht.com — Cisco Umbrella Rank: 252	3 KB
1	ytimg.com i.ytimg.com — Cisco Umbrella Rank: 123	21 KB
1	googletagmanager.com www.googletagmanager.com — Cisco Umbrella Rank: 82	81 KB
1	dripemail2.com 1 redirects t.dripemail2.com — Cisco Umbrella Rank: 160844	284 B
73	12

	Domain	Requested by
30	biopharmaapac.com	biopharmaapac.com
11	www.gstatic.com	www.youtube.com www.gstatic.com www.google.com
9	www.youtube.com	biopharmaapac.com www.youtube.com
8	www.google.com	biopharmaapac.com www.youtube.com www.gstatic.com www.google.com
4	jnn-pa.googleapis.com	www.youtube.com
2	googleads.g.doubleclick.net	1 redirects www.youtube.com
2	fonts.gstatic.com	www.youtube.com
2	platform.twitter.com	biopharmaapac.com platform.twitter.com
1	syndication.twitter.com	platform.twitter.com
1	www.google-analytics.com	www.googletagmanager.com
1	yt3.ggpht.com	www.youtube.com
1	i.ytimg.com	www.youtube.com
1	static.doubleclick.net	www.youtube.com
1	www.googletagmanager.com	biopharmaapac.com
1	t.dripemail2.com	1 redirects
73	15

This site contains links to these domains. Also see Links.

Domain
www.mastercontrol.com
www.bdbiosciences.com
event.on24.com
www.biopharmaapac.com
somalogic.com
bioasiataiwan.com
www.linkedin.com
twitter.com

Subject Issuer	Validity	Valid
biopharmaapac.com R3	`2023-05-10` - `2023-08-08`	3 months	crt.sh
*.google.com GTS CA 1C3	`2023-05-22` - `2023-08-14`	3 months	crt.sh
www.google.com GTS CA 1C3	`2023-05-22` - `2023-08-14`	3 months	crt.sh
*.twimg.com DigiCert TLS RSA SHA256 2020 CA1	`2022-10-06` - `2023-11-06`	a year	crt.sh
*.google-analytics.com GTS CA 1C3	`2023-05-22` - `2023-08-14`	3 months	crt.sh
*.gstatic.com GTS CA 1C3	`2023-05-22` - `2023-08-14`	3 months	crt.sh
*.doubleclick.net GTS CA 1C3	`2023-05-22` - `2023-08-14`	3 months	crt.sh
upload.video.google.com GTS CA 1C3	`2023-05-22` - `2023-08-14`	3 months	crt.sh
edgestatic.com GTS CA 1C3	`2023-05-22` - `2023-08-14`	3 months	crt.sh
*.googleusercontent.com GTS CA 1C3	`2023-05-22` - `2023-08-14`	3 months	crt.sh
syndication.twitter.com DigiCert TLS RSA SHA256 2020 CA1	`2023-01-31` - `2024-01-30`	a year	crt.sh

This page contains 7 frames:

Primary Page: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
Frame ID: 41AE32A569B1A0DD635E8490D7044C60
Requests: 35 HTTP requests in this frame

Frame: https://www.youtube.com/embed/oOiLZblZZdU
Frame ID: 6ABA26B5705B98982A7DB0757D2C3D6D
Requests: 21 HTTP requests in this frame

Frame: https://platform.twitter.com/widgets/widget_iframe.2b2d73daf636805223fb11d48f3e94f7.html?origin=https%3A%2F%2Fbiopharmaapac.com
Frame ID: 83D45A12779A3CD699B334AC43A61922
Requests: 2 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=SglpK98hSCn2CroR0bKRSJl5&size=normal&cb=7lqhitfk2dek
Frame ID: 149250B586D4683E0B94BBE5EBB75F28
Requests: 4 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=SglpK98hSCn2CroR0bKRSJl5&size=normal&cb=o9uzoln8pjkl
Frame ID: 0A514EFEB267452A8A9F1768AE3DD064
Requests: 4 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=en&v=SglpK98hSCn2CroR0bKRSJl5&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: 2D478B957CFA7E5EB2B8F87E13EF4C98
Requests: 3 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/bframe?hl=en&v=SglpK98hSCn2CroR0bKRSJl5&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC
Frame ID: F710CA4CCEF2980D8DA1AA033682C0E1
Requests: 3 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page Title

FDA Approves Phase I/II Trial for Leads Biolabs' Anti-MUC16/CD3 Bispecific Antibody in Advanced Solid Tumors.

Page URL History Show full URLs

https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6I... HTTP 307
https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-... Page URL

Detected technologies

Bootstrap (Web Frameworks) Expand

Overall confidence: 100%
Detected patterns

<link[^>]* href=[^>]*?bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.css
bootstrap(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)[^>]*?(?:\.min)?\.js

Font Awesome (Font Scripts) Expand

Overall confidence: 100%
Detected patterns

<link[^>]* href=[^>]+(?:([\d.]+)/)?(?:css/)?font-awesome(?:\.min)?\.css
<link[^>]* href=[^>]*?(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:[^>]*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)
(?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Google Analytics (Analytics) Expand

Overall confidence: 100%
Detected patterns

Google Tag Manager (Tag Managers) Expand

Overall confidence: 100%
Detected patterns

googletagmanager\.com/gtag/js

Twitter (Widgets) Expand

Overall confidence: 100%
Detected patterns

//platform\.twitter\.com/widgets\.js

jQuery (JavaScript Libraries) Expand

Overall confidence: 100%
Detected patterns

jquery[.-]([\d.]*\d)[^/]*\.js
jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

reCAPTCHA (Captchas) Expand

Overall confidence: 100%
Detected patterns

/recaptcha/api\.js

Page Statistics

73
Requests

99 %
HTTPS

87 %
IPv6

12
Domains

15
Subdomains

15
IPs

3
Countries

3494 kB
Transfer

8086 kB
Size

5
Cookies

9 Outgoing links

These are links going to different origins than the main page.

URL: https://www.mastercontrol.com/au/resource-center/documents/the-state-of-digital-quality-maturity-in-pharma-and-medtech?utm_campaign=7013x00000204FhAAI&utm_medium=Email&utm_source=SI

Search URL Search Domain Scan URL

URL: https://www.bdbiosciences.com/en-us/learn/campaigns/clinical-brilliance-amplified

Search URL Search Domain Scan URL

URL: https://www.mastercontrol.com/uk/library/ultimate-guide/digitising-manufacturing-pharma-industry/?utm_campaign=7013x0000020IeqAAE&utm_medium=Email&utm_source=SI

Search URL Search Domain Scan URL

URL: https://event.on24.com/wcc/r/4211352/0E5B49372C5DDFDB8AB82D21B37E0569?partnerref=biopdis

Search URL Search Domain Scan URL

URL: https://www.biopharmaapac.com/edtorial-calendar-2023

Search URL Search Domain Scan URL

URL: https://somalogic.com/somascan-assay/

Search URL Search Domain Scan URL

URL: https://bioasiataiwan.com/en/registration/plan

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/biopharmaapac-news

Search URL Search Domain Scan URL

URL: https://twitter.com/BiopharmaApac

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNjg3MTQzOTAzLCJuYmYiOjE2ODcxNDM5MDMsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZGVsaXZlcnlfaWQiOiI4ZWd4a3loaDA3bzE0dG92OTB0MCIsInVybCI6Imh0dHBzOi8vYmlvcGhhcm1hYXBhYy5jb20vbmV3cy85Mi8zMjcxL2ZkYS1hcHByb3Zlcy1waGFzZS1pLWlpLXRyaWFsLWZvci1sZWFkcy1iaW9sYWJzLWFudGktbXVjMTYtY2QzLWJpc3BlY2lmaWMtYW50aWJvZHktaW4tYWR2YW5jZWQtc29saWQtdHVtb3JzLS5odG1sP19fcz03d2g0Zms2NXVsMmpmY3Rna3c0biZ1dG1fc291cmNlPWRyaXAmdXRtX21lZGl1bT1lbWFpbCZ1dG1fY2FtcGFpZ249QXN0cmFaZW5lY2ErQ29sbGFib3JhdGVzK3dpdGgrQ2hvbGVzZ2VuK2ZvcitIeXBlcmNob2xlc3Rlcm9sZW1pYStEcnVnK0Rpc2NvdmVyeSthbmQrTGljZW5zaW5nK0FncmVlbWVudCJ9.Jhoo49d1NUR5VEQxtwIWhbeDLryCgk_2zgh90pgm9no HTTP 307
https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 39

https://googleads.g.doubleclick.net/pagead/id HTTP 302
https://googleads.g.doubleclick.net/pagead/id?slf_rd=1

73 HTTP transactions
1 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2

200

Primary Request fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html Show response
biopharmaapac.com/news/92/3271/
Redirect Chain

https://t.dripemail2.com/c/eyJhbGciOiJIUzI1NiJ9.eyJhdWQiOiJkZXRvdXIiLCJpc3MiOiJtb25vbGl0aCIsInN1YiI6ImRldG91cl9saW5rIiwiaWF0IjoxNjg3MTQzOTAzLCJuYmYiOjE2ODcxNDM5MDMsImFjY291bnRfaWQiOiI2MTU3NjEzIiwiZ...
https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm...

53 KB
15 KB

953ms
467ms

Document
text/html

2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed / PHP/7.0.33

Resource Hash

e47cef6ac3e52844354cdc4370a3cbf5533b7a84ddc912f5631d882a818ff88c

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36
accept-language: en-CA,en;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"
cache-control: no-cache
content-encoding: br
content-security-policy: upgrade-insecure-requests
content-type: text/html; charset=UTF-8
date: Mon, 19 Jun 2023 04:16:22 GMT
platform: hostinger
server: LiteSpeed
vary: Accept-Encoding
x-powered-by: PHP/7.0.33

Redirect headers

content-length: 0
date: Mon, 19 Jun 2023 04:16:21 GMT
location: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement

GET
H2 200 bootstrap.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 157 KB
31 KB 236ms
234ms Stylesheet
text/css 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/bootstrap.min.css

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

f77c0d1739b618edc4a01ca3f6b2990b01a3009030af49ee8cf68e83052df194

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "27288-6140a349-7859833689cc7ca2;br"
vary: Accept-Encoding
content-type: text/css
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 style.css
biopharmaapac.com/bundles/taai/app/site/css/ 25 KB
7 KB 469ms
468ms Stylesheet
text/css 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/style.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

ebdc5cfff9a360616e819fbd3cb79de32c18c8cc9bf5fde761c69b015ccab1d5

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Fri, 14 Oct 2022 06:41:01 GMT
server: LiteSpeed
etag: "6585-6349047d-66af6bb1b2ad8d51;br"
vary: Accept-Encoding
content-type: text/css
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 font-awesome.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 20 KB
5 KB 471ms
470ms Stylesheet
text/css 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

b769324e0921f9f649611113e65f528ebae5e140da8a7e63c5d6ea7bc7a33bc0

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "511e-6140a349-e988c72e9ba3081c;br"
vary: Accept-Encoding
content-type: text/css
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 normalize.min.css
biopharmaapac.com/bundles/taai/app/site/css/ 2 KB
1 KB 472ms
471ms Stylesheet
text/css 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/normalize.min.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

b76ffbb2665f82b493e054b50d3d1bb3f2a8b4233be1795ca9937956eef196bc

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "897-6140a349-28911982800b5b4e;br"
vary: Accept-Encoding
content-type: text/css
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 custom-style.css
biopharmaapac.com/bundles/taai/app/site/css/ 342 B
298 B 473ms
473ms Stylesheet
text/css 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/css/custom-style.css

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

e65117229d77c2ee86fca1f8753df08d81434bf55569e574a03bcabce77ce436

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "156-6140a349-3b24c466283853f0;br"
vary: Accept-Encoding
content-type: text/css
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 oOiLZblZZdU Show response
www.youtube.com/embed/ Frame 6ABA 77 KB
32 KB 136ms
84ms Document
text/html 2607:f8b0:4020:805::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/embed/oOiLZblZZdU

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:805::200e Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

58ce50bd58391082b0cd85a2d58716bc8933427d80316e4b7ced95a2d526f10b

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36
accept-language: en-CA,en;q=0.9

Response headers

accept-ch: Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: br
content-type: text/html; charset=utf-8
cross-origin-opener-policy-report-only: same-origin; report-to="youtube_main"
cross-origin-resource-policy: cross-origin
date: Mon, 19 Jun 2023 04:16:22 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
origin-trial: AvC9UlR6RDk2crliDsFl66RWLnTbHrDbp+DiY6AYz/PNQ4G4tdUTjrHYr2sghbkhGQAVxb7jaPTHpEVBz0uzQwkAAAB4eyJvcmlnaW4iOiJodHRwczovL3lvdXR1YmUuY29tOjQ0MyIsImZlYXR1cmUiOiJXZWJWaWV3WFJlcXVlc3RlZFdpdGhEZXByZWNhdGlvbiIsImV4cGlyeSI6MTcxOTUzMjc5OSwiaXNTdWJkb21haW4iOnRydWV9
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657?hl=en for more info."
permissions-policy: ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
pragma: no-cache
report-to: {"group":"youtube_main","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube_main"}]}
server: ESF
strict-transport-security: max-age=31536000
vary: Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
x-content-type-options: nosniff
x-xss-protection: 0

GET
H2 200 logo.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 39 KB
39 KB 238ms
233ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/logo.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

d997981b750d83dcba2e00d81538fec720b77fddf3862399d79beae42ca8659c

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "9b6f-6140a349-d159c02c989eed78;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 39791
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 23q1_qx_cicero_research_report_kop_teal_emea_v1a_728x90-58.png
biopharmaapac.com/uploads/static/ 17 KB
17 KB 448ms
442ms Image
image/png 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/23q1_qx_cicero_research_report_kop_teal_emea_v1a_728x90-58.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

d8940c31a7f4ad50ef01825ec53553a1a030b175a7c128b949229fbb3b2a551a

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Wed, 26 Apr 2023 10:00:32 GMT
server: LiteSpeed
etag: "44cd-6448f640-5b2cabe5f5b4a2cd;;;"
content-type: image/png
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 17613
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 14189024047208381311-59.jpg
biopharmaapac.com/uploads/static/ 98 KB
98 KB 450ms
444ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/14189024047208381311-59.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

ac2307091696f9c5e1850dfda0c34f76ef23f8db4144240297ce80d185148b64

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 23 May 2023 04:22:41 GMT
server: LiteSpeed
etag: "1886e-646c3f91-f8149fcdce66e628;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 100462
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 oip-3271.jpg
biopharmaapac.com/uploads/articles/ 34 KB
34 KB 469ms
464ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/articles/oip-3271.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

4f3b48ff2c7269bac17d7f6dda773af163530aeb6aa74afb99110c6396ade32a

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Mon, 19 Jun 2023 02:38:15 GMT
server: LiteSpeed
etag: "88d5-648fbf97-154fbe00bce98d4;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 35029
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 22q4_ug_mx_pharma_kop_emea_display_social_banners_opt_2_800x200_1_-2105.png
biopharmaapac.com/uploads/static/ 75 KB
75 KB 469ms
464ms Image
image/png 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/22q4_ug_mx_pharma_kop_emea_display_social_banners_opt_2_800x200_1_-2105.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

f8e5b00bb951d9aac7e2a82c2e69dc036b5c4aa67ababff890b0f817eccee775

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Fri, 26 May 2023 02:43:36 GMT
server: LiteSpeed
etag: "12b95-64701cd8-f8c7135030fa4d9a;;;"
content-type: image/png
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 76693
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 single_use_300_x250_available_on_demand-61.png
biopharmaapac.com/uploads/static/ 75 KB
75 KB 469ms
465ms Image
image/png 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/single_use_300_x250_available_on_demand-61.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

3daf57c5cf8567fab332c34fba457daefc4ddbdf569cd96b9d23922e8bf398a2

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Thu, 15 Jun 2023 06:13:04 GMT
server: LiteSpeed
etag: "12d33-648aabf0-b88e7c1127fb285;;;"
content-type: image/png
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 77107
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 untitled-64.png
biopharmaapac.com/uploads/static/ 31 KB
31 KB 470ms
465ms Image
image/png 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/untitled-64.png

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

87eb19ea32f1644fba1d4639cc125c511c25ee6d0605b800e4c7b4c07dadf214

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Mon, 19 Dec 2022 04:06:47 GMT
server: LiteSpeed
etag: "7b3c-639fe357-91f4331af4ac5700;;;"
content-type: image/png
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 31548
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 9358600487417395077-62.jpg
biopharmaapac.com/uploads/static/ 69 KB
69 KB 469ms
465ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/9358600487417395077-62.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

5965a6d5f8d82851a4e5caf5377be9fb37bfd6cf13c45bacfacdcdcb709d92df

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Mon, 15 May 2023 15:35:42 GMT
server: LiteSpeed
etag: "114a7-6462514e-16739f4e838c3cd4;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 70823
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 2023_banner_w300xh250-63.jpg
biopharmaapac.com/uploads/static/ 28 KB
28 KB 469ms
466ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/static/2023_banner_w300xh250-63.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

0e0ae848601388c1da9d649e0df1b287f38b9d5e3247acceb3cf4386c8d9f7b0

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 18 Apr 2023 03:13:47 GMT
server: LiteSpeed
etag: "7103-643e0aeb-4c6f0dca8c9975ce;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 28931
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 r-3189.jpg
biopharmaapac.com/uploads/articles/ 105 KB
105 KB 469ms
466ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/articles/r-3189.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

6b7231eb2d2eece352e50dd99e800bf88d6f437ef847209660b869eb94e96582

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Thu, 01 Jun 2023 10:42:13 GMT
server: LiteSpeed
etag: "1a298-64787605-ba853fed70964d9f;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 107160
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 precision_medicine-3188.jpg
biopharmaapac.com/uploads/articles/ 43 KB
43 KB 469ms
466ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/articles/precision_medicine-3188.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

6522561dc6ea4f9e4d81211357118c1e35921d3eec3eaf201f09317297b90378

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Thu, 01 Jun 2023 10:35:35 GMT
server: LiteSpeed
etag: "ab2b-64787477-83562aa1d89793e2;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 43819
expires: Mon, 26 Jun 2023 04:16:22 GMT

GET
H2 200 cdfa17955345a81e0c965764aa20861f-3187.jpg
biopharmaapac.com/uploads/articles/ 42 KB
42 KB 677ms
674ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/uploads/articles/cdfa17955345a81e0c965764aa20861f-3187.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

7faa348e52d0eee83291910c3d1f1c2c6137fc406ae1c1d22fe5d6fbcb286c4d

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Thu, 01 Jun 2023 10:25:19 GMT
server: LiteSpeed
etag: "a629-6478720f-c40a202055e2b24b;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 42537
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H2 200 BPA-Newsletter.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 94 KB
94 KB 939ms
938ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/BPA-Newsletter.jpg

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

4e43e7bdb59b9ba8fc890be3bf4a501b4b50d46f22b3be93b57c40d8052b819b

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "178aa-6140a349-407c7922f9bf9a24;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 96426
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H2 200 jquery-3.6.0.min.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 87 KB
36 KB 692ms
692ms Script
application/x-javascript 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/jquery-3.6.0.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

ff1523fb7389539c84c65aba19260648793bb4f5e29329d2ee8804bc37a3fe6e

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "15d9d-6140a349-430f3cd6fca331c8;br"
vary: Accept-Encoding
content-type: application/x-javascript
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H2 200 popper.min.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 21 KB
8 KB 691ms
687ms Script
application/x-javascript 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/popper.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

c776195ad46333c6c9a9fe3c74502ffea9a02faf122388ea3567922cc65a3060

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "5309-6140a349-c4616dbb00ef16dd;br"
vary: Accept-Encoding
content-type: application/x-javascript
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H2 200 bootstrap.min.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 62 KB
18 KB 691ms
687ms Script
application/x-javascript 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/bootstrap.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

d8968086f7509df34c3278563dab87399da4f9dcdfb419818e3a309eedc70b88

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "f708-6140a349-5238856086bc9dd1;br"
vary: Accept-Encoding
content-type: application/x-javascript
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H2 200 jquery.autoscroll.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 1 KB
874 B 691ms
688ms Script
application/x-javascript 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/jquery.autoscroll.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

c6be6411d784cb509362d794eb35273a24661f430ef0858982cac95fbb23e23d

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "59b-6140a349-887b402685ae2c08;br"
vary: Accept-Encoding
content-type: application/x-javascript
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H2 200 script.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 8 KB
2 KB 691ms
688ms Script
application/x-javascript 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/script.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

6ac1a1a6d852a4b597abee6351f122b5363f1c3f153df5a2b60336bbbe61069d

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "1ed5-6140a349-4ae31db006d61650;br"
vary: Accept-Encoding
content-type: application/x-javascript
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H2 200 dips-site-common.js Show response
biopharmaapac.com/bundles/taai/app/site/js/ 5 KB
2 KB 691ms
688ms Script
application/x-javascript 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/js/dips-site-common.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

b316099d3d0439715256c4bf9b8b59f2323a0af63e65b33e668a1eb3972f2893

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "13f4-6140a349-f8f1d2a3132f82ea;br"
vary: Accept-Encoding
content-type: application/x-javascript
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H2 200 api.js Show response
www.google.com/recaptcha/ 850 B
876 B 79ms
39ms Script
text/javascript 2607:f8b0:4020:805::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:805::2004 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

41be1cf66d5f2a5e356d650205c8a6031fa238bcdef0a4d1e167712ab643fd51

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
x-frame-options: SAMEORIGIN
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=300
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 556
x-xss-protection: 1; mode=block
expires: Mon, 19 Jun 2023 04:16:22 GMT

GET
H/1.1 200
OK widgets.js Show response
platform.twitter.com/ 91 KB
28 KB 91ms
19ms Script
application/javascript 2606:2800:220:de:468:2285:c1:4a3
EDGECAST

General

Check archive.org

Show headers Download Go to

Full URL: https://platform.twitter.com/widgets.js
Requested by: Host: biopharmaapac.com
URL: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 2606:2800:220:de:468:2285:c1:4a3 , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software: ECS (nyb/1D22) /
Resource Hash: 392c9fa9cd1273a2a89d1a83a69cd1f63f21d1d55e7be21e1d8f51f25145668b

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

Date: Mon, 19 Jun 2023 04:16:22 GMT
Content-Encoding: gzip
Age: 945
x-amz-server-side-encryption: AES256
X-Cache: HIT
P3P: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server-Timing: x-cache;desc= HIT,x-tw-cdn;desc=VZ
Content-Length: 27630
Last-Modified: Tue, 24 Jan 2023 21:41:51 GMT
Server: ECS (nyb/1D22)
Etag: "9e99725b7a4cd730a934afba2a438bb5+gzip"
Access-Control-Max-Age: 3000
Access-Control-Allow-Methods: GET
Content-Type: application/javascript; charset=utf-8
Access-Control-Allow-Origin: *
x-tw-cdn: VZ
Cache-Control: public, max-age=1800
Vary: Accept-Encoding

GET
H2 200 articulate.min.js Show response
biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/ 8 KB
3 KB 691ms
688ms Script
application/x-javascript 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/assets/global/plugins/text-to-speech/articulate.min.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

a8a2031f7cb98a60f55670a991ce71d4b61aaf051a4bf4eaccb2620b218516ec

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/news/92/3271/fda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html?__s=7wh4fk65ul2jfctgkw4n&utm_source=drip&utm_medium=email&utm_campaign=AstraZeneca+Collaborates+with+Cholesgen+for+Hypercholesterolemia+Drug+Discovery+and+Licensing+Agreement
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:35 GMT
server: LiteSpeed
etag: "1e7c-6140a347-9dc90f273839c854;br"
vary: Accept-Encoding
content-type: application/x-javascript
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H2 200 js Show response
www.googletagmanager.com/gtag/ 229 KB
81 KB 92ms
43ms Script
application/javascript 2607:f8b0:4006:80d::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4006:80d::2008 Flushing, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

ff8c4561b47718279f4c9fe44741f75051cbaa86cdc7daa5edb52f4045db8883

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:22 GMT
content-encoding: br
strict-transport-security: max-age=31536000; includeSubDomains
server: Google Tag Manager
vary: Accept-Encoding
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
access-control-allow-headers: Cache-Control
content-length: 82758
x-xss-protection: 0
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires: Mon, 19 Jun 2023 04:16:22 GMT

GET
H2 200 www-player.css
www.youtube.com/s/player/6ed0d907/ Frame 6ABA 410 KB
48 KB 14ms
13ms Stylesheet
text/css 2607:f8b0:4020:805::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/6ed0d907/www-player.css

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/oOiLZblZZdU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:805::200e Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

bb2709731f5398ffb835d8845f6f4c78f052d7b7792c810b14d443c0f2094724

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/embed/oOiLZblZZdU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Fri, 16 Jun 2023 14:59:19 GMT
content-encoding: br
x-content-type-options: nosniff
age: 220623
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 49278
x-xss-protection: 0
last-modified: Wed, 14 Jun 2023 01:47:13 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Sat, 15 Jun 2024 14:59:19 GMT

GET
H2 200 KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v18/ Frame 6ABA 15 KB
16 KB 60ms
12ms Font
font/woff2 2607:f8b0:4020:804::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/roboto/v18/KFOmCnqEu92Fr1Mu4mxK.woff2

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/oOiLZblZZdU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:804::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

3e253b66056519aa065b00a453bac37ac5ed8f3e6fe7b542e93a9dcdcc11d0bc

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.youtube.com/
Origin: https://www.youtube.com
accept-language: en-CA,en;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Fri, 16 Jun 2023 14:59:20 GMT
x-content-type-options: nosniff
age: 220623
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 15344
x-xss-protection: 0
last-modified: Mon, 16 Oct 2017 17:32:55 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sat, 15 Jun 2024 14:59:20 GMT

GET
H2 200 KFOlCnqEu92Fr1MmEU9fBBc4.woff2
fonts.gstatic.com/s/roboto/v18/ Frame 6ABA 15 KB
15 KB 62ms
15ms Font
font/woff2 2607:f8b0:4020:804::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://fonts.gstatic.com/s/roboto/v18/KFOlCnqEu92Fr1MmEU9fBBc4.woff2

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/oOiLZblZZdU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:804::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

5a8c1e7681318caa29e9f44e8a6e271f6a4067a2703e9916dfd4fe9099241db7

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.youtube.com/
Origin: https://www.youtube.com
accept-language: en-CA,en;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Fri, 16 Jun 2023 20:49:12 GMT
x-content-type-options: nosniff
age: 199631
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 15552
x-xss-protection: 0
last-modified: Mon, 16 Oct 2017 17:33:02 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="apps-themes"
report-to: {"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type: font/woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sat, 15 Jun 2024 20:49:12 GMT

GET
H3 200 www-embed-player.js Show response
www.youtube.com/s/player/6ed0d907/www-embed-player.vflset/ Frame 6ABA 308 KB
93 KB 15ms
12ms Script
text/javascript 2607:f8b0:4020:805::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/6ed0d907/www-embed-player.vflset/www-embed-player.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/oOiLZblZZdU

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::200e Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

2b566d22c0563b579149060354f5b869a6721f5b9543c07a7509928a8e6687d5

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/embed/oOiLZblZZdU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Sat, 17 Jun 2023 00:08:38 GMT
content-encoding: br
x-content-type-options: nosniff
age: 187664
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 94811
x-xss-protection: 0
last-modified: Wed, 14 Jun 2023 01:47:13 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Sun, 16 Jun 2024 00:08:38 GMT

GET
H3 200 base.js Show response
www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/ Frame 6ABA 2 MB
745 KB 16ms
14ms Script
text/javascript 2607:f8b0:4020:805::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/base.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/oOiLZblZZdU

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::200e Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

0f6314e85a3a7ad560fc4fab29201e90b72ffef8a5b65ef1e9b977134969df6e

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/embed/oOiLZblZZdU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Fri, 16 Jun 2023 17:56:46 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 209976
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 762773
x-xss-protection: 0
last-modified: Wed, 14 Jun 2023 01:47:13 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Sat, 15 Jun 2024 17:56:46 GMT

GET
H3 200 fetch-polyfill.js Show response
www.youtube.com/s/player/6ed0d907/fetch-polyfill.vflset/ Frame 6ABA 9 KB
3 KB 21ms
19ms Script
text/javascript 2607:f8b0:4020:805::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/6ed0d907/fetch-polyfill.vflset/fetch-polyfill.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/oOiLZblZZdU

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::200e Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

ac8177161c3038b07597ec544de3c00f46e1a0aa6b4b4c045ff0495553cc5069

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/embed/oOiLZblZZdU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Thu, 15 Jun 2023 02:57:17 GMT
content-encoding: br
x-content-type-options: nosniff
age: 350345
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 2625
x-xss-protection: 0
last-modified: Wed, 14 Jun 2023 01:47:13 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Fri, 14 Jun 2024 02:57:17 GMT

GET
H3 200 back-web.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 180 KB
180 KB 234ms
233ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/back-web.jpg

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

847bedbf9186a36abc8402681b8008ace8c6bd698130bb53317a82cf3e6df40c

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "2ce33-6140a349-a245902176c11e6a;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
alt-svc: h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"
content-length: 183859
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H3 200 newsletter-back-Banner.jpg
biopharmaapac.com/bundles/taai/app/site/images/ 67 KB
67 KB 602ms
598ms Image
image/jpeg 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/newsletter-back-Banner.jpg

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

703407ec12879bbe9920345dcba6c5ed3a4903e311e4662c3f369bd5092eb5b4

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "10a92-6140a349-33172d275368fc77;;;"
content-type: image/jpeg
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
content-length: 68242
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H3 200 cd-icon-close.svg
biopharmaapac.com/bundles/taai/app/site/images/ 696 B
508 B 604ms
601ms Image
image/svg+xml 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://biopharmaapac.com/bundles/taai/app/site/images/cd-icon-close.svg

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/style.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

ba3c42c97d16d249855dcfeed7daf64b7a6f56bb45948a5b6409c39bf037da92

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/bundles/taai/app/site/css/style.css
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: br
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "2b8-6140a349-1a40af30861b987e;br"
vary: Accept-Encoding
content-type: image/svg+xml
cache-control: public, max-age=604800
accept-ranges: bytes
platform: hostinger
expires: Mon, 26 Jun 2023 04:16:23 GMT

GET
H3 200 fontawesome-webfont.woff
biopharmaapac.com/bundles/taai/app/site/fonts/ 82 KB
82 KB 236ms
233ms Font
application/font-woff 2a02:4780:3:644:0:683:abf2:2
AS-HOSTINGER

General

Check archive.org

Show headers Download Go to

Full URL

https://biopharmaapac.com/bundles/taai/app/site/fonts/fontawesome-webfont.woff?v=4.1.0

Requested by

Host: biopharmaapac.com
URL: https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css

Protocol

Security

QUIC, , AES_128_GCM

Server

2a02:4780:3:644:0:683:abf2:2 , Singapore, ASN47583 (AS-HOSTINGER, CY),

Reverse DNS

Software

LiteSpeed /

Resource Hash

66db52b456efe7e29cec11fa09421d03cb09e37ed1b567307ec0444fd605ce31

Security Headers

Name	Value
Content-Security-Policy	upgrade-insecure-requests

Request headers

Referer: https://biopharmaapac.com/bundles/taai/app/site/css/font-awesome.min.css
Origin: https://biopharmaapac.com
accept-language: en-CA,en;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-security-policy: upgrade-insecure-requests
last-modified: Tue, 14 Sep 2021 13:27:37 GMT
server: LiteSpeed
etag: "14730-6140a349-4838eff778c56c55;;;"
content-type: application/font-woff
accept-ranges: bytes
platform: hostinger
content-length: 83760

GET
H2

200

id Show response
googleads.g.doubleclick.net/pagead/ Frame 6ABA
Redirect Chain

https://googleads.g.doubleclick.net/pagead/id
https://googleads.g.doubleclick.net/pagead/id?slf_rd=1

100 B
242 B

33ms
33ms

XHR
application/json

2607:f8b0:4020:807::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://googleads.g.doubleclick.net/pagead/id?slf_rd=1

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/oOiLZblZZdU

Protocol

Server

2607:f8b0:4020:807::2002 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

932f433f7b3081ffbb20e9b482c29d4b229f7099724fe5cba9048c4fb4a24fa4

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy: cross-origin
content-disposition: attachment; filename="f.txt"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 120
x-xss-protection: 0
pragma: no-cache
server: cafe
content-type: application/json; charset=UTF-8
access-control-allow-origin: https://www.youtube.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

date: Mon, 19 Jun 2023 04:16:23 GMT
x-content-type-options: nosniff
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
x-xss-protection: 0
pragma: no-cache
server: cafe
content-type: text/html; charset=UTF-8
location: https://googleads.g.doubleclick.net/pagead/id?slf_rd=1
access-control-allow-origin: https://www.youtube.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ad_status.js Show response
static.doubleclick.net/instream/ Frame 6ABA 29 B
494 B 70ms
11ms Script
text/javascript 2607:f8b0:4020:806::2006
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://static.doubleclick.net/instream/ad_status.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/6ed0d907/www-embed-player.vflset/www-embed-player.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:806::2006 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

eed0dc1fdb5d97ed188ae16fd5e1024a5bb744af47340346be2146300a6c54b9

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:11:11 GMT
x-content-type-options: nosniff
age: 312
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 29
x-xss-protection: 0
last-modified: Thu, 12 Dec 2013 23:40:16 GMT
server: sffe
report-to: {"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=900
accept-ranges: bytes
timing-allow-origin: *
cross-origin-opener-policy-report-only: same-origin; report-to="ads-doubleclick-media"
expires: Mon, 19 Jun 2023 04:26:11 GMT

OPTIONS
H2 200 Create
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame 0
0 83ms
28ms Preflight
text/html 2607:f8b0:4020:804::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/Create

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:804::200a Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Accept: */*
Access-Control-Request-Headers: content-type,x-goog-api-key,x-user-agent
Access-Control-Request-Method: POST
Origin: https://www.youtube.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

access-control-allow-credentials: true
access-control-allow-headers: content-type,x-goog-api-key,x-user-agent
access-control-allow-methods: DELETE,GET,HEAD,OPTIONS,PATCH,POST,PUT
access-control-allow-origin: https://www.youtube.com
access-control-max-age: 3600
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
content-type: text/html
date: Mon, 19 Jun 2023 04:16:23 GMT
server: ESF
vary: origin referer x-origin
x-content-type-options: nosniff
x-frame-options: SAMEORIGIN
x-xss-protection: 0

POST
H2 200 Create Show response
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame 6ABA 67 KB
31 KB 40ms
38ms XHR
application/json+protobuf 2607:f8b0:4020:804::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/Create

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/base.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:804::200a Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

0e10520c13d8e0ec55ca666eab92c71995829e6b139d1a87a520915c9ce04b72

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

X-User-Agent: grpc-web-javascript/0.1
Referer: https://www.youtube.com/
X-Goog-Api-Key: AIzaSyDyT5W0Jh49F30Pqqtyfdf7pDLFKLJoAnw
accept-language: en-CA,en;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36
Content-Type: application/json+protobuf

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: ESF
vary: Origin, X-Origin, Referer
x-frame-options: SAMEORIGIN
content-type: application/json+protobuf; charset=UTF-8
access-control-allow-origin: https://www.youtube.com
access-control-expose-headers: vary,vary,vary,content-encoding,date,server,content-length
cache-control: private
access-control-allow-credentials: true
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 31496
x-xss-protection: 0

GET
H3 200 remote.js Show response
www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/ Frame 6ABA 116 KB
33 KB 14ms
14ms Script
text/javascript 2607:f8b0:4020:805::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/remote.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/base.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::200e Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

bbc43fbe83523a411116e9306425076377a46878fe5f92f24a3c24083508761a

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/embed/oOiLZblZZdU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Sat, 17 Jun 2023 05:46:28 GMT
content-encoding: br
x-content-type-options: nosniff
age: 167395
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 33409
x-xss-protection: 0
last-modified: Wed, 14 Jun 2023 01:47:13 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Sun, 16 Jun 2024 05:46:28 GMT

GET
H2 200 kIU7Dnjt7cuOEQgpBtbUVnmdXpyYzgDR0B1Wt-nxWZk.js Show response
www.google.com/js/th/ Frame 6ABA 37 KB
15 KB 13ms
12ms Script
text/javascript 2607:f8b0:4020:805::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/js/th/kIU7Dnjt7cuOEQgpBtbUVnmdXpyYzgDR0B1Wt-nxWZk.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/base.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:805::2004 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

90853b0e78ededcb8e11082906d6d456799d5e9c98ce00d1d01d56b7e9f15999

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Sat, 17 Jun 2023 04:22:15 GMT
content-encoding: br
x-content-type-options: nosniff
age: 172448
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 14689
x-xss-protection: 0
last-modified: Mon, 05 Jun 2023 09:30:00 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="botguard-scs"
vary: Accept-Encoding
report-to: {"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Sun, 16 Jun 2024 04:22:15 GMT

GET
H2 200 sddefault.webp
i.ytimg.com/vi_webp/oOiLZblZZdU/ Frame 6ABA 20 KB
21 KB 85ms
19ms Image
image/webp 2607:f8b0:4006:80a::2016
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://i.ytimg.com/vi_webp/oOiLZblZZdU/sddefault.webp

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/oOiLZblZZdU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4006:80a::2016 Flushing, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

bc015b90a36fd1a2f117e80f99bcb9420781637d489bc9f2f7f943f31c86b830

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 03:54:44 GMT
x-content-type-options: nosniff
age: 1299
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 20624
x-xss-protection: 0
server: sffe
etag: "1674165976"
vary: Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: image/webp
cache-control: public, max-age=7200
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Mon, 19 Jun 2023 05:54:44 GMT

GET
H3 200 embed.js Show response
www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/ Frame 6ABA 28 KB
8 KB 12ms
11ms Script
text/javascript 2607:f8b0:4020:805::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/embed.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/base.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::200e Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

80fb80514c12a7553a218d4022959811bc4b4a8b9a0c72502ceeccf134845890

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/embed/oOiLZblZZdU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Fri, 16 Jun 2023 10:59:21 GMT
content-encoding: br
x-content-type-options: nosniff
age: 235022
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 8088
x-xss-protection: 0
last-modified: Wed, 14 Jun 2023 01:47:13 GMT
server: sffe
vary: Accept-Encoding, Origin
report-to: {"group":"youtube","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/youtube"}]}
content-type: text/javascript
cache-control: public, max-age=31536000
accept-ranges: bytes
cross-origin-opener-policy-report-only: same-origin; report-to="youtube"
expires: Sat, 15 Jun 2024 10:59:21 GMT

GET
DATA 200
OK truncated
/ Frame 6ABA 175 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 67ea46bc3d15351067faccb3613bd833dd3f15137a4b4a09f2e873fd41d024d2

Request headers

accept-language: en-CA,en;q=0.9
Referer
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 CyIKCkPDpCy3sZAfB1fcdVyaGXE9ASVMB435nwEWdWGdnSz832aaszFZ2e8n0o1jh127gYVPow=s68-c-k-c0x00ffffff-no-rj
yt3.ggpht.com/ Frame 6ABA 2 KB
3 KB 78ms
20ms Image
image/jpeg 2607:f8b0:4006:80b::2001
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://yt3.ggpht.com/CyIKCkPDpCy3sZAfB1fcdVyaGXE9ASVMB435nwEWdWGdnSz832aaszFZ2e8n0o1jh127gYVPow=s68-c-k-c0x00ffffff-no-rj

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/embed/oOiLZblZZdU

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4006:80b::2001 Flushing, United States, ASN15169 (GOOGLE, US),

Reverse DNS

Software

fife /

Resource Hash

8cd06b6d745df6a5d7931603ec39f00129086ad5eedee0316904fee8a53f793c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 02:46:35 GMT
x-content-type-options: nosniff
age: 5388
content-disposition: inline;filename="channels4_profile.jpg"
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 2382
x-xss-protection: 0
server: fife
etag: "v1"
vary: Origin
content-type: image/jpeg
access-control-allow-origin: *
access-control-expose-headers: Content-Length
cache-control: public, max-age=86400, no-transform
timing-allow-origin: *
expires: Tue, 20 Jun 2023 02:46:35 GMT

GET
H3 204 generate_204
www.youtube.com/ Frame 6ABA 0
10 B 12ms
11ms Image
text/plain 2607:f8b0:4020:805::200e
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.youtube.com/generate_204?ukDmOg
Requested by: Host: www.youtube.com
URL: https://www.youtube.com/embed/oOiLZblZZdU
Protocol: H3
Security: QUIC, , AES_128_GCM
Server: 2607:f8b0:4020:805::200e Montreal, Canada, ASN15169 (GOOGLE, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/embed/oOiLZblZZdU
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0

POST
H3 200 GenerateIT Show response
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame 6ABA 90 B
134 B 30ms
27ms XHR
application/json+protobuf 2607:f8b0:4020:804::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/GenerateIT

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/base.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:804::200a Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

a7cf99897b108c163eab30395a900e128e12a4a182331cb832b17e40388588c5

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

X-User-Agent: grpc-web-javascript/0.1
Referer: https://www.youtube.com/
X-Goog-Api-Key: AIzaSyDyT5W0Jh49F30Pqqtyfdf7pDLFKLJoAnw
accept-language: en-CA,en;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36
Content-Type: application/json+protobuf

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: ESF
vary: Origin, X-Origin, Referer
x-frame-options: SAMEORIGIN
content-type: application/json+protobuf; charset=UTF-8
access-control-allow-origin: https://www.youtube.com
access-control-expose-headers: vary,vary,vary,content-encoding,date,server,content-length
cache-control: private
access-control-allow-credentials: true
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 110
x-xss-protection: 0

OPTIONS
H3 200 GenerateIT
jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/ Frame 0
0 27ms
26ms Preflight
text/html 2607:f8b0:4020:804::200a
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://jnn-pa.googleapis.com/$rpc/google.internal.waa.v1.Waa/GenerateIT

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:804::200a Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

ESF /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

Accept: */*
Access-Control-Request-Headers: content-type,x-goog-api-key,x-user-agent
Access-Control-Request-Method: POST
Origin: https://www.youtube.com
Sec-Fetch-Mode: cors
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

access-control-allow-credentials: true
access-control-allow-headers: content-type,x-goog-api-key,x-user-agent
access-control-allow-methods: DELETE,GET,HEAD,OPTIONS,PATCH,POST,PUT
access-control-allow-origin: https://www.youtube.com
access-control-max-age: 3600
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
content-type: text/html
date: Mon, 19 Jun 2023 04:16:23 GMT
server: ESF
vary: origin referer x-origin
x-content-type-options: nosniff
x-frame-options: SAMEORIGIN
x-xss-protection: 0

GET
H2 200 cast_sender.js Show response
www.gstatic.com/cv/js/sender/v1/ Frame 6ABA 4 KB
2 KB 73ms
32ms Script
text/javascript 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/cv/js/sender/v1/cast_sender.js

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/6ed0d907/player_ias.vflset/en_US/base.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

ee147e859ad0f09aa50367974e38ab53e7c7054c4a51d400a7f45b0eb251454f

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/cloudview
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 2007
x-xss-protection: 0
last-modified: Tue, 16 Feb 2021 23:57:06 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="cloudview"
vary: Accept-Encoding
report-to: {"group":"cloudview","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/cloudview"}]}
content-type: text/javascript
cache-control: private, max-age=3000
accept-ranges: bytes
expires: Mon, 19 Jun 2023 04:16:23 GMT

GET
H2 200 cast_sender.js Show response
www.gstatic.com/eureka/clank/114/ Frame 6ABA 51 KB
15 KB 12ms
11ms Script
text/javascript 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/eureka/clank/114/cast_sender.js

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/cv/js/sender/v1/cast_sender.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

184de53a881ec8e4e218974c548e2fc8e0da4b8ddaff2e7bdc6267c6e70a8636

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.youtube.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Sun, 18 Jun 2023 14:33:35 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 49368
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/cloudview-release
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 15225
x-xss-protection: 0
last-modified: Mon, 17 Apr 2023 15:04:47 GMT
server: sffe
cross-origin-opener-policy: same-origin; report-to="cloudview-release"
vary: Accept-Encoding
report-to: {"group":"cloudview-release","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/cloudview-release"}]}
content-type: text/javascript
cache-control: public, max-age=86400
accept-ranges: bytes
expires: Mon, 19 Jun 2023 14:33:35 GMT

GET
H3 200 recaptcha__en.js Show response
www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/ 416 KB
167 KB 39ms
12ms Script
text/javascript 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/recaptcha__en.js

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

752d16411f4866d01a2fc6c8f984da8104367e264a8865a63714e2f8181f5a73

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://biopharmaapac.com/
Origin: https://biopharmaapac.com
accept-language: en-CA,en;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 02:15:05 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 7278
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 170572
x-xss-protection: 0
last-modified: Sun, 11 Jun 2023 18:00:29 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Tue, 18 Jun 2024 02:15:05 GMT

POST
H2 204 collect
www.google-analytics.com/g/ 0
255 B 73ms
32ms Ping
text/plain 2607:f8b0:4020:807::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://www.google-analytics.com/g/collect?v=2&tid=G-2E2BXNMKP4&gtm=45je36e0&_p=880914873&cid=903909522.1687148184&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&_s=1&sid=1687148183&sct=1&seg=0&dl=https%3A%2F%2Fbiopharmaapac.com%2Fnews%2F92%2F3271%2Ffda-approves-phase-i-ii-trial-for-leads-biolabs-anti-muc16-cd3-bispecific-antibody-in-advanced-solid-tumors-.html%3F__s%3D7wh4fk65ul2jfctgkw4n%26utm_source%3Ddrip%26utm_medium%3Demail%26utm_campaign%3DAstraZeneca%2BCollaborates%2Bwith%2BCholesgen%2Bfor%2BHypercholesterolemia%2BDrug%2BDiscovery%2Band%2BLicensing%2BAgreement&dt=FDA%20Approves%20Phase%20I%2FII%20Trial%20for%20Leads%20Biolabs%27%20Anti-MUC16%2FCD3%20Bispecific%20Antibody%20in%20Advanced%20Solid%20Tumors.&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1
Requested by: Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-2E2BXNMKP4
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2607:f8b0:4020:807::200e Montreal, Canada, ASN15169 (GOOGLE, US),
Reverse DNS
Software: Golfe2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://biopharmaapac.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

pragma: no-cache
date: Mon, 19 Jun 2023 04:16:23 GMT
server: Golfe2
content-type: text/plain
access-control-allow-origin: https://biopharmaapac.com
cache-control: no-cache, no-store, must-revalidate
access-control-allow-credentials: true
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H/1.1 200
OK widget_iframe.2b2d73daf636805223fb11d48f3e94f7.html Show response
platform.twitter.com/widgets/ Frame 83D4 320 KB
104 KB 21ms
21ms Document
text/html 2606:2800:220:de:468:2285:c1:4a3
EDGECAST

General

Check archive.org

Show headers Download Go to

Full URL: https://platform.twitter.com/widgets/widget_iframe.2b2d73daf636805223fb11d48f3e94f7.html?origin=https%3A%2F%2Fbiopharmaapac.com
Requested by: Host: platform.twitter.com
URL: https://platform.twitter.com/widgets.js
Protocol: HTTP/1.1
Security: TLS 1.3, , AES_256_GCM
Server: 2606:2800:220:de:468:2285:c1:4a3 , United States, ASN15133 (EDGECAST, US),
Reverse DNS
Software: ECS (nyb/1D0F) /
Resource Hash: 4002d65e95f94dc87ae8ad170eb8dbc3644921032ac76dcb376537d9304a6fbf

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36
accept-language: en-CA,en;q=0.9

Response headers

Access-Control-Allow-Methods: GET
Access-Control-Allow-Origin: *
Age: 4430645
Cache-Control: public, max-age=315360000
Content-Encoding: gzip
Content-Length: 105435
Content-Type: text/html; charset=utf-8
Date: Mon, 19 Jun 2023 04:16:23 GMT
Etag: "95e1b50b0c179aefb47b5b211bb347b5+gzip"
Last-Modified: Tue, 24 Jan 2023 21:41:13 GMT
P3P: CP="CAO DSP LAW CURa ADMa DEVa TAIa PSAa PSDa IVAa IVDa OUR BUS IND UNI COM NAV INT"
Server: ECS (nyb/1D0F)
Server-Timing: x-cache;desc= HIT,x-tw-cdn;desc=VZ
Vary: Accept-Encoding
X-Cache: HIT
x-amz-server-side-encryption: AES256
x-tw-cdn: VZ

GET
H3 200 anchor Show response
www.google.com/recaptcha/api2/ Frame 1492 51 KB
28 KB 59ms
58ms Document
text/html 2607:f8b0:4020:805::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=SglpK98hSCn2CroR0bKRSJl5&size=normal&cb=7lqhitfk2dek

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/recaptcha__en.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2004 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

e80c5eae09d621c2d0c7a0a342d7e0d0c397bd6cbdb96d220391e204a23f256d

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-Gy9_laua03jNrtYRY2eADA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36
accept-language: en-CA,en;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-length: 28668
content-security-policy: script-src 'report-sample' 'nonce-Gy9_laua03jNrtYRY2eADA' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Mon, 19 Jun 2023 04:16:23 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H3 200 anchor Show response
www.google.com/recaptcha/api2/ Frame 0A51 51 KB
28 KB 54ms
54ms Document
text/html 2607:f8b0:4020:805::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=SglpK98hSCn2CroR0bKRSJl5&size=normal&cb=o9uzoln8pjkl

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/recaptcha__en.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2004 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

4c9f04fc8a790772d50ac9abc0b3d6de3f27b939f81c765ead564697a5eebbd0

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-7AOke-B6haxJDOchKygCYw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36
accept-language: en-CA,en;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-length: 28631
content-security-policy: script-src 'report-sample' 'nonce-7AOke-B6haxJDOchKygCYw' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Mon, 19 Jun 2023 04:16:23 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H2 200 settings Show response
syndication.twitter.com/ Frame 83D4 870 B
659 B 171ms
53ms Fetch
application/json 104.244.42.200
TWITTER

General

Check archive.org

Show headers Download Go to

Full URL

https://syndication.twitter.com/settings?session_id=f8f5cf268fcf65656f2cfdea970a8bd466530a9a

Requested by

Host: platform.twitter.com
URL: https://platform.twitter.com/widgets/widget_iframe.2b2d73daf636805223fb11d48f3e94f7.html?origin=https%3A%2F%2Fbiopharmaapac.com

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

104.244.42.200 , United States, ASN13414 (TWITTER, US),

Reverse DNS

Software

tsa_b /

Resource Hash

8ec44a4b321f5115d8760f193298585d8b28a26dd3190d0a3690b9e09a489a94

Security Headers

Name	Value
Strict-Transport-Security	max-age=631138519

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://platform.twitter.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

x-response-time: 5
date: Mon, 19 Jun 2023 04:16:24 GMT
content-encoding: gzip
strict-transport-security: max-age=631138519
last-modified: Mon, 19 Jun 2023 04:16:24 GMT
server: tsa_b
vary: Origin
content-type: application/json; charset=utf-8
access-control-allow-origin: https://platform.twitter.com
x-transaction-id: 9da90d3abe382a71
cache-control: must-revalidate, max-age=600
access-control-allow-credentials: true
perf: 7626143928
x-connection-hash: 1e2f88f5e06013fab11aafbdac82d55b633a4f44f3a89f1c75fb01688f159a4f
content-length: 338

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/ Frame 0A51 55 KB
24 KB 16ms
12ms Stylesheet
text/css 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/styles__ltr.css

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=SglpK98hSCn2CroR0bKRSJl5&size=normal&cb=o9uzoln8pjkl

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

952833e41ba7a4b64c31a2d7b07dde81bf5bbacf5cbb967821cfe459d0c4a0d8

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Sat, 17 Jun 2023 04:31:36 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 171887
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24605
x-xss-protection: 0
last-modified: Sun, 11 Jun 2023 18:00:29 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Sun, 16 Jun 2024 04:31:36 GMT

GET
H3 200 recaptcha__en.js Show response
www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/ Frame 0A51 416 KB
167 KB 25ms
21ms Script
text/javascript 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/recaptcha__en.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

752d16411f4866d01a2fc6c8f984da8104367e264a8865a63714e2f8181f5a73

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 02:15:05 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 7278
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 170572
x-xss-protection: 0
last-modified: Sun, 11 Jun 2023 18:00:29 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Tue, 18 Jun 2024 02:15:05 GMT

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/ Frame 1492 55 KB
24 KB 17ms
13ms Stylesheet
text/css 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/styles__ltr.css

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

952833e41ba7a4b64c31a2d7b07dde81bf5bbacf5cbb967821cfe459d0c4a0d8

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Sat, 17 Jun 2023 04:31:36 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 171887
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24605
x-xss-protection: 0
last-modified: Sun, 11 Jun 2023 18:00:29 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Sun, 16 Jun 2024 04:31:36 GMT

GET
H3 200 recaptcha__en.js Show response
www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/ Frame 1492 416 KB
167 KB 28ms
25ms Script
text/javascript 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/recaptcha__en.js

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

752d16411f4866d01a2fc6c8f984da8104367e264a8865a63714e2f8181f5a73

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 02:15:05 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 7278
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 170572
x-xss-protection: 0
last-modified: Sun, 11 Jun 2023 18:00:29 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Tue, 18 Jun 2024 02:15:05 GMT

GET
H3 200 webworker.js
www.google.com/recaptcha/api2/ Frame 0A51 102 B
133 B 49ms
49ms Other
text/javascript 2607:f8b0:4020:805::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/webworker.js?hl=en&v=SglpK98hSCn2CroR0bKRSJl5

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2004 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

58f4ef3230aa0f2d13e67db42cfc271f4067c1afb88073758edc15ca79e477b6

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=SglpK98hSCn2CroR0bKRSJl5&size=normal&cb=o9uzoln8pjkl
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:24 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
cross-origin-embedder-policy: require-corp
x-frame-options: SAMEORIGIN
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=300
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 111
x-xss-protection: 1; mode=block
expires: Mon, 19 Jun 2023 04:16:24 GMT

GET
H3 200 webworker.js
www.google.com/recaptcha/api2/ Frame 1492 102 B
133 B 39ms
39ms Other
text/javascript 2607:f8b0:4020:805::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/webworker.js?hl=en&v=SglpK98hSCn2CroR0bKRSJl5

Requested by

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2004 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

58f4ef3230aa0f2d13e67db42cfc271f4067c1afb88073758edc15ca79e477b6

Security Headers

Name	Value
Content-Security-Policy	frame-ancestors 'self'
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	1; mode=block

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.google.com/recaptcha/api2/anchor?ar=1&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC&co=aHR0cHM6Ly9iaW9waGFybWFhcGFjLmNvbTo0NDM.&hl=en&v=SglpK98hSCn2CroR0bKRSJl5&size=normal&cb=7lqhitfk2dek
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 04:16:24 GMT
content-encoding: gzip
x-content-type-options: nosniff
content-security-policy: frame-ancestors 'self'
server: GSE
cross-origin-embedder-policy: require-corp
x-frame-options: SAMEORIGIN
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=300
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 111
x-xss-protection: 1; mode=block
expires: Mon, 19 Jun 2023 04:16:24 GMT

GET
H3 200 bframe Show response
www.google.com/recaptcha/api2/ Frame 2D47 7 KB
1 KB 42ms
41ms Document
text/html 2607:f8b0:4020:805::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/bframe?hl=en&v=SglpK98hSCn2CroR0bKRSJl5&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/recaptcha__en.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2004 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

8414f430a043e6a343210c3e19470a39ca1f4b57310f3341751f815721f7c5dc

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-OMxf6Mg5H40W0jkiJjWw6Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36
accept-language: en-CA,en;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-length: 1156
content-security-policy: script-src 'report-sample' 'nonce-OMxf6Mg5H40W0jkiJjWw6Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Mon, 19 Jun 2023 04:16:24 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H3 200 bframe Show response
www.google.com/recaptcha/api2/ Frame F710 7 KB
1 KB 45ms
44ms Document
text/html 2607:f8b0:4020:805::2004
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.google.com/recaptcha/api2/bframe?hl=en&v=SglpK98hSCn2CroR0bKRSJl5&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Requested by

Host: www.gstatic.com
URL: https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/recaptcha__en.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2004 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

GSE /

Resource Hash

bfca47640ad426a1f569b58d988bbd4f4a33fadbbf20850392d624ca6c560d69

Security Headers

Name	Value
Content-Security-Policy	script-src 'report-sample' 'nonce-1ltUTb57KEq-YLZpEyku2Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://biopharmaapac.com/
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36
accept-language: en-CA,en;q=0.9

Response headers

alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control: no-cache, no-store, max-age=0, must-revalidate
content-encoding: gzip
content-length: 1155
content-security-policy: script-src 'report-sample' 'nonce-1ltUTb57KEq-YLZpEyku2Q' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-type: text/html; charset=utf-8
cross-origin-embedder-policy: require-corp
cross-origin-resource-policy: cross-origin
date: Mon, 19 Jun 2023 04:16:24 GMT
expires: Mon, 01 Jan 1990 00:00:00 GMT
pragma: no-cache
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
server: GSE
x-content-type-options: nosniff
x-xss-protection: 1; mode=block

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/ Frame 2D47 55 KB
24 KB 12ms
12ms Stylesheet
text/css 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/styles__ltr.css

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=en&v=SglpK98hSCn2CroR0bKRSJl5&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

952833e41ba7a4b64c31a2d7b07dde81bf5bbacf5cbb967821cfe459d0c4a0d8

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Sat, 17 Jun 2023 04:31:36 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 171888
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24605
x-xss-protection: 0
last-modified: Sun, 11 Jun 2023 18:00:29 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Sun, 16 Jun 2024 04:31:36 GMT

GET
H3 200 recaptcha__en.js Show response
www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/ Frame 2D47 416 KB
167 KB 14ms
13ms Script
text/javascript 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/recaptcha__en.js

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=en&v=SglpK98hSCn2CroR0bKRSJl5&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

752d16411f4866d01a2fc6c8f984da8104367e264a8865a63714e2f8181f5a73

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 02:15:05 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 7279
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 170572
x-xss-protection: 0
last-modified: Sun, 11 Jun 2023 18:00:29 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Tue, 18 Jun 2024 02:15:05 GMT

GET
H3 200 styles__ltr.css
www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/ Frame F710 55 KB
24 KB 13ms
12ms Stylesheet
text/css 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/styles__ltr.css

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=en&v=SglpK98hSCn2CroR0bKRSJl5&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

952833e41ba7a4b64c31a2d7b07dde81bf5bbacf5cbb967821cfe459d0c4a0d8

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Sat, 17 Jun 2023 04:31:36 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 171888
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 24605
x-xss-protection: 0
last-modified: Sun, 11 Jun 2023 18:00:29 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/css
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Sun, 16 Jun 2024 04:31:36 GMT

GET
H3 200 recaptcha__en.js Show response
www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/ Frame F710 416 KB
167 KB 14ms
14ms Script
text/javascript 2607:f8b0:4020:805::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.gstatic.com/recaptcha/releases/SglpK98hSCn2CroR0bKRSJl5/recaptcha__en.js

Requested by

Host: www.google.com
URL: https://www.google.com/recaptcha/api2/bframe?hl=en&v=SglpK98hSCn2CroR0bKRSJl5&k=6LcBzPsaAAAAAOt0kNH-YlJctO-SRQwTP5mEryWC

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::2003 Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

752d16411f4866d01a2fc6c8f984da8104367e264a8865a63714e2f8181f5a73

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
Referer: https://www.google.com/
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36

Response headers

date: Mon, 19 Jun 2023 02:15:05 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 7279
content-security-policy-report-only: require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/recaptcha
cross-origin-resource-policy: cross-origin
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 170572
x-xss-protection: 0
last-modified: Sun, 11 Jun 2023 18:00:29 GMT
server: sffe
cross-origin-opener-policy: same-origin-allow-popups; report-to="recaptcha"
vary: Accept-Encoding
report-to: {"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
content-type: text/javascript
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
expires: Tue, 18 Jun 2024 02:15:05 GMT

POST
H3 200 log_event Show response
www.youtube.com/youtubei/v1/ Frame 6ABA 28 B
50 B 43ms
43ms XHR
application/json 2607:f8b0:4020:805::200e
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.youtube.com/youtubei/v1/log_event?alt=json&key=AIzaSyAO_FJ2SlqU8Q4STEHLGCilw_Y9_11qcW8

Requested by

Host: www.youtube.com
URL: https://www.youtube.com/s/player/6ed0d907/www-embed-player.vflset/www-embed-player.js

Protocol

Security

QUIC, , AES_128_GCM

Server

2607:f8b0:4020:805::200e Montreal, Canada, ASN15169 (GOOGLE, US),

Reverse DNS

Software

scaffolding on HTTPServer2 /

Resource Hash

d7d5e54ad1e33d7ab49c664323ced79cb9723ff15e9764cd0edc3e15208e8336

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN
X-Xss-Protection	0

Request headers

accept-language: en-CA,en;q=0.9
User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/114.0.5735.133 Safari/537.36
X-Goog-Request-Time: 1687148185226
Content-Type: application/json
X-YouTube-Utc-Offset: 0
X-YouTube-Client-Name: 56
Referer: https://www.youtube.com/embed/oOiLZblZZdU
X-YouTube-Client-Version: 1.20230613.01.00
X-YouTube-Time-Zone: Etc/Unknown
X-Goog-Visitor-Id: Cgt6V3BnVnJCR1JmbyiWrb-kBg%3D%3D
X-YouTube-Ad-Signals: dt=1687148183032&flash=0&frm=2&u_tz&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&bc=31&bih=-12245933&biw=-12245933&brdim=0%2C0%2C0%2C0%2C1600%2C0%2C1600%2C1200%2C350%2C200&vis=1&wgl=true&ca_type=image

Response headers

date: Mon, 19 Jun 2023 04:16:25 GMT
content-encoding: br
x-content-type-options: nosniff
server: scaffolding on HTTPServer2
x-frame-options: SAMEORIGIN
vary: Origin, X-Origin, Referer
content-type: application/json; charset=UTF-8
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length: 31
x-xss-protection: 0

Verdicts & Comments Add Verdict or Comment

44 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

5 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
biopharmaapac.com/	1969-12-31 23:59:59	Name: PHPSESSID Value: s3tc23irr6k0geuujf9g9a6la6
.youtube.com/	1969-12-31 23:59:59	Name: YSC Value: 4RKwyrNW6MM
.youtube.com/	1970-01-20 16:58:20	Name: VISITOR_INFO1_LIVE Value: zWpgVrBGRfo
.biopharmaapac.com/	1970-01-20 22:15:08	Name: _ga_2E2BXNMKP4 Value: GS1.1.1687148183.1.0.1687148183.0.0.0
.biopharmaapac.com/	1970-01-20 22:15:08	Name: _ga Value: GA1.1.903909522.1687148184

1 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
security	warning	Message: Error with Permissions-Policy header: Unrecognized feature: 'ch-ua-form-factor'.

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
Content-Security-Policy	upgrade-insecure-requests

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

biopharmaapac.com
fonts.gstatic.com
googleads.g.doubleclick.net
i.ytimg.com
jnn-pa.googleapis.com
platform.twitter.com
static.doubleclick.net
syndication.twitter.com
t.dripemail2.com
www.google-analytics.com
www.google.com
www.googletagmanager.com
www.gstatic.com
www.youtube.com
yt3.ggpht.com
104.244.42.200
2606:2800:220:de:468:2285:c1:4a3
2607:f8b0:4006:80a::2016
2607:f8b0:4006:80b::2001
2607:f8b0:4006:80d::2008
2607:f8b0:4020:804::2003
2607:f8b0:4020:804::200a
2607:f8b0:4020:805::2003
2607:f8b0:4020:805::2004
2607:f8b0:4020:805::200e
2607:f8b0:4020:806::2006
2607:f8b0:4020:807::2002
2607:f8b0:4020:807::200e
2a02:4780:3:644:0:683:abf2:2
34.193.159.116
0e0ae848601388c1da9d649e0df1b287f38b9d5e3247acceb3cf4386c8d9f7b0
0e10520c13d8e0ec55ca666eab92c71995829e6b139d1a87a520915c9ce04b72
0f6314e85a3a7ad560fc4fab29201e90b72ffef8a5b65ef1e9b977134969df6e
184de53a881ec8e4e218974c548e2fc8e0da4b8ddaff2e7bdc6267c6e70a8636
2b566d22c0563b579149060354f5b869a6721f5b9543c07a7509928a8e6687d5
392c9fa9cd1273a2a89d1a83a69cd1f63f21d1d55e7be21e1d8f51f25145668b
3daf57c5cf8567fab332c34fba457daefc4ddbdf569cd96b9d23922e8bf398a2
3e253b66056519aa065b00a453bac37ac5ed8f3e6fe7b542e93a9dcdcc11d0bc
4002d65e95f94dc87ae8ad170eb8dbc3644921032ac76dcb376537d9304a6fbf
41be1cf66d5f2a5e356d650205c8a6031fa238bcdef0a4d1e167712ab643fd51
4c9f04fc8a790772d50ac9abc0b3d6de3f27b939f81c765ead564697a5eebbd0
4e43e7bdb59b9ba8fc890be3bf4a501b4b50d46f22b3be93b57c40d8052b819b
4f3b48ff2c7269bac17d7f6dda773af163530aeb6aa74afb99110c6396ade32a
58ce50bd58391082b0cd85a2d58716bc8933427d80316e4b7ced95a2d526f10b
58f4ef3230aa0f2d13e67db42cfc271f4067c1afb88073758edc15ca79e477b6
5965a6d5f8d82851a4e5caf5377be9fb37bfd6cf13c45bacfacdcdcb709d92df
5a8c1e7681318caa29e9f44e8a6e271f6a4067a2703e9916dfd4fe9099241db7
6522561dc6ea4f9e4d81211357118c1e35921d3eec3eaf201f09317297b90378
66db52b456efe7e29cec11fa09421d03cb09e37ed1b567307ec0444fd605ce31
67ea46bc3d15351067faccb3613bd833dd3f15137a4b4a09f2e873fd41d024d2
6ac1a1a6d852a4b597abee6351f122b5363f1c3f153df5a2b60336bbbe61069d
6b7231eb2d2eece352e50dd99e800bf88d6f437ef847209660b869eb94e96582
703407ec12879bbe9920345dcba6c5ed3a4903e311e4662c3f369bd5092eb5b4
752d16411f4866d01a2fc6c8f984da8104367e264a8865a63714e2f8181f5a73
7faa348e52d0eee83291910c3d1f1c2c6137fc406ae1c1d22fe5d6fbcb286c4d
80fb80514c12a7553a218d4022959811bc4b4a8b9a0c72502ceeccf134845890
8414f430a043e6a343210c3e19470a39ca1f4b57310f3341751f815721f7c5dc
847bedbf9186a36abc8402681b8008ace8c6bd698130bb53317a82cf3e6df40c
87eb19ea32f1644fba1d4639cc125c511c25ee6d0605b800e4c7b4c07dadf214
8cd06b6d745df6a5d7931603ec39f00129086ad5eedee0316904fee8a53f793c
8ec44a4b321f5115d8760f193298585d8b28a26dd3190d0a3690b9e09a489a94
90853b0e78ededcb8e11082906d6d456799d5e9c98ce00d1d01d56b7e9f15999
932f433f7b3081ffbb20e9b482c29d4b229f7099724fe5cba9048c4fb4a24fa4
952833e41ba7a4b64c31a2d7b07dde81bf5bbacf5cbb967821cfe459d0c4a0d8
a7cf99897b108c163eab30395a900e128e12a4a182331cb832b17e40388588c5
a8a2031f7cb98a60f55670a991ce71d4b61aaf051a4bf4eaccb2620b218516ec
ac2307091696f9c5e1850dfda0c34f76ef23f8db4144240297ce80d185148b64
ac8177161c3038b07597ec544de3c00f46e1a0aa6b4b4c045ff0495553cc5069
b316099d3d0439715256c4bf9b8b59f2323a0af63e65b33e668a1eb3972f2893
b769324e0921f9f649611113e65f528ebae5e140da8a7e63c5d6ea7bc7a33bc0
b76ffbb2665f82b493e054b50d3d1bb3f2a8b4233be1795ca9937956eef196bc
ba3c42c97d16d249855dcfeed7daf64b7a6f56bb45948a5b6409c39bf037da92
bb2709731f5398ffb835d8845f6f4c78f052d7b7792c810b14d443c0f2094724
bbc43fbe83523a411116e9306425076377a46878fe5f92f24a3c24083508761a
bc015b90a36fd1a2f117e80f99bcb9420781637d489bc9f2f7f943f31c86b830
bfca47640ad426a1f569b58d988bbd4f4a33fadbbf20850392d624ca6c560d69
c6be6411d784cb509362d794eb35273a24661f430ef0858982cac95fbb23e23d
c776195ad46333c6c9a9fe3c74502ffea9a02faf122388ea3567922cc65a3060
d7d5e54ad1e33d7ab49c664323ced79cb9723ff15e9764cd0edc3e15208e8336
d8940c31a7f4ad50ef01825ec53553a1a030b175a7c128b949229fbb3b2a551a
d8968086f7509df34c3278563dab87399da4f9dcdfb419818e3a309eedc70b88
d997981b750d83dcba2e00d81538fec720b77fddf3862399d79beae42ca8659c
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
e47cef6ac3e52844354cdc4370a3cbf5533b7a84ddc912f5631d882a818ff88c
e65117229d77c2ee86fca1f8753df08d81434bf55569e574a03bcabce77ce436
e80c5eae09d621c2d0c7a0a342d7e0d0c397bd6cbdb96d220391e204a23f256d
ebdc5cfff9a360616e819fbd3cb79de32c18c8cc9bf5fde761c69b015ccab1d5
ee147e859ad0f09aa50367974e38ab53e7c7054c4a51d400a7f45b0eb251454f
eed0dc1fdb5d97ed188ae16fd5e1024a5bb744af47340346be2146300a6c54b9
f77c0d1739b618edc4a01ca3f6b2990b01a3009030af49ee8cf68e83052df194
f8e5b00bb951d9aac7e2a82c2e69dc036b5c4aa67ababff890b0f817eccee775
ff1523fb7389539c84c65aba19260648793bb4f5e29329d2ee8804bc37a3fe6e
ff8c4561b47718279f4c9fe44741f75051cbaa86cdc7daa5edb52f4045db8883

biopharmaapac.com Open in urlscan Pro 2a02:4780:3:644:0:683:abf2:2 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page Title

Page URL History Show full URLs

Detected technologies

Page Statistics

73 Requests

99 %HTTPS

87 %IPv6

12 Domains

15 Subdomains

15 IPs

3 Countries

3494 kBTransfer

8086 kBSize

5 Cookies

9 Outgoing links

Page URL History

Redirected requests

73 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 1 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

biopharmaapac.com Open in urlscan Pro
2a02:4780:3:644:0:683:abf2:2 Public Scan

Screenshot
Live screenshot

Full Image

73
Requests

99 %
HTTPS

87 %
IPv6

12
Domains

15
Subdomains

15
IPs

3
Countries

3494 kB
Transfer

8086 kB
Size

5
Cookies

73 HTTP transactions
1 data transactions